High-cost drugs, generative AI, diagnostic testing – the pace and sophistication of healthcare innovation has been keeping our experts busy over the past several years. At some point, they realized there was something deeper going on – a sea change in what healthcare innovation is seeking to achieve, and the world it's pushing us toward.
This week, host Abby Burns invites Advisory Board innovation experts Solomon Banjo and Nick Hula to talk about a new era of innovation, where progress in diagnostics, treatments, data analysis, and ongoing management have the potential to revolutionize patient care through unprecedented customization. They define what "bespoke care" is, explain how it differs from other delivery models, and highlight the opportunities (and challenges) it presents.
Links:
New advances in treatment and diagnostics have the potential to deliver on one of healthcare's greatest unrealized promises: truly personalized, patient-focused care. But how can a system designed to deliver fast, standardized treatment realign itself to offer "bespoke care" to patients at scale? Visit advisory.com/bespoke to learn 4 key challenges standing in the way – and how to overcome them.
Radio Advisory is celebrating its four-year anniversary this month! Tell us about your favorite episode, what you like about the podcast, and how we can continue to do better by emailing podcasts@advisory.com or leave us a voicemail through radioadvisory.advisory.com. Thanks for listening!
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
You have 10 free members-only resources remaining this month.
You've reached your limit of free monthly insights